Acquisition of Products or Companies

Acquiring new products or companies brings both opportunities and challenges, especially when it comes to pharmacovigilance (PV) obligations. At MedWatch Consulting, we help ensure that safety systems are fully assessed, integrated, and compliant throughout the acquisition process.

Our team conducts due diligence, gap analysis, and system audits to identify potential PV risks and ensure smooth transitions. We support the integration of safety databases, Standard Operating Procedures (SOPs), and Safety Data Exchange Agreements (SDEAs) to align new assets with your existing PV system.

By providing both technical and regulatory expertise, we help you minimize risks, maintain compliance, and create a strong foundation for the successful launch and long-term safety management of your newly acquired products or companies.

Discover more

PV support with licensing in/out of products

We provide PV support for licensing deals, ensuring clear safety agreements and full compliance.

Learn more

Co-development agreements

We help define PV responsibilities and agreements in co-development partnerships.

Learn more

Distributors, agents, and commercial partners in new markets

We align distributors and partners in new markets with global PV compliance standards.

Learn more

Mergers and joint ventures

We support PV integration and compliance during mergers and joint ventures.

Learn more

Development of PV agreements, safety data exchange agreements

We draft and manage PVAs and SDEAs that ensure clear safety responsibilities and compliance.

Learn more

KPI development and monitoring

We design and track KPIs that measure compliance, quality, and efficiency in PV systems.

Learn more